Amarin Corp Plc (AMRN)

[KCSVEN]

Am I missing the half the population quote? ICER said half of adults will be effected by CVD and because of that fact a large population would be eligible for Vascepa. In this case eligible for Vascepa will require being on a statin so for the foreseeable future the populaton is a percent of statin users.

Amarin seems to have said very little about EVAPORATE, in the filing they say RESPECT-EPA results in second half 2021, when they talk about EVAPORATE they don't mention any end date in the filing despite it supposedly ending September. Have not read transcripts but was the end date mentioned at all on call today? Seems odd they have very little update on this trial.